EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells

Yichao Hou iD, Xintian Zhang, Han Yao, Lidan Hou, Qingwei Zhang, Enwei Tao, Xiaoqiang Zhu iD, Shanshan Jiang, Yimeng Ren, Xialu Hong, Shiyuan Lu, Xiaoxu Leng und 7 weitere

EMBO Reports · 05.04.2023 · 24 (4)

DOI: 10.15252/embr.202256325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Reports, online erschienen am 16.02.2023. Verfasst von Yichao Hou und 18 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Gut Microecology and Associated Major Diseases Research, Digestive Disease Research and Clinical Translation Center, Depar…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, MicroRNAs. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), Shanghai Pujiang Program, The Interdisciplinary of Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The frequency of p53 mutations in colorectal cancer (CRC) is approximately 40–50%. A variety of therapies are being developed to target tumors expressing mutant p53. However, potential therapeutic targets for CRC expressing wild‐type p53 are rare. In this study, we show that METTL14 is transcriptionally activated by wild‐type p53 and suppresses tumor growth only in p53‐wild‐type (p53‐WT) CRC cells. METTL14 deletion promotes both AOM/DSS and AOM‐induced CRC growth in mouse models with the intestinal epithelial cell‐specific knockout of METTL14. Additionally, METTL14 restrains aerobic glycolysis in p53‐WT CRC, by repressing SLC2A3 and PGAM1 expression via selectively promoting m 6 A‐YTHDF2‐dependent pri‐miR‐6769b/pri‐miR‐499a processing. Biosynthetic mature miR‐6769b‐3p and miR‐499a‐3p decrease SLC2A3 and PGAM1 levels, respectively, and suppress malignant phenotypes. Clinically, METTL14 only acts as a beneficial prognosis factor for the overall survival of p53‐WT CRC patients. These results uncover a new mechanism for METTL14 inactivation in tumors and, most importantly, reveal that the activation of METTL14 is a critical mechanism for p53‐dependent cancer growth inhibition, which could be targeted for therapy in p53‐WT CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMicroRNAsAnimalsMiceCarcinogenesisCell Line, TumorCell ProliferationCell Transformation, NeoplasticGene Expression Regulation, NeoplasticGlycolysisTumor Suppressor Protein p53Methyltransferases

Stichwörter der Autor:innen

METTL14aerobic glycolysiscolorectal cancerm6Awild-type p53

Substanzen

MicroRNAsTumor Suppressor Protein p53Mettl14 protein, mouseMethyltransferases

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Gut Microecology and Associated Major Diseases Research, Digestive Disease Research and Clinical Translation Center, Department of Gastroenterology, Shanghai Ninth People's Hospital, School of…
  • State Key Laboratory for Oncogenes and Related Genes, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, Renji Ho…

ORCID-Profile: Yichao Hou, Xiaoqiang Zhu, Jing-Yuan Fang, Xiangjun Meng

Förderung

  • National Natural Science Foundation of China (NSFC)
  • Shanghai Pujiang Program
  • The Interdisciplinary of Shanghai Jiao Tong University
  • The Shanghai Sailing Program

Zitieren

APA

Hou, Y., Zhang, X., Yao, H., Hou, L., Zhang, Q., Tao, E., Zhu, X., Jiang, S., Ren, Y., Hong, X., Lu, S., Leng, X., Xie, Y., Gao, Y., Liang, Y., Zhong, T., Long, B., Fang, J. Y., & Meng, X. (2023). METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells. EMBO Reports, 24(4). https://doi.org/10.15252/embr.202256325

Vancouver

Hou Y, Zhang X, Yao H, Hou L, Zhang Q, Tao E, et al. METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells. EMBO Reports. 2023;24(4). doi:10.15252/embr.202256325

BibTeX
@article{Hou2023,
  author = {Hou, Yichao and Zhang, Xintian and Yao, Han and Hou, Lidan and Zhang, Qingwei and Tao, Enwei and Zhu, Xiaoqiang and Jiang, Shanshan and Ren, Yimeng and Hong, Xialu and Lu, Shiyuan and Leng, Xiaoxu and Xie, Yile and Gao, Yaqi and Liang, Yu and Zhong, Ting and Long, Bohan and Fang, Jing-Yuan and Meng, Xiangjun},
  title = {METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells},
  journal = {EMBO Reports},
  year = {2023},
  volume = {24},
  number = {4},
  doi = {10.15252/embr.202256325}
}
Kostenlos starten →